Total revenues down 2.5 percent to 29.4 billion euros in 2Q; internal revenue growth of 0.4 percent in 2Q, adjusted for currencies and consolidation / 2Q operating profit down 17.2 percent to 2.4 billion euros, impacted by natural catastrophes and exceptional effects / 2Q operating profit in Asset Management stabilizing, assets under management up versus 1Q / Value of new business in Life/Health up 62.2 percent in 2Q, new business margin up to 2.6 percent / Net income attributable to shareholders down 46.0 percent to 1.1 billion euros in 2Q, driven by 352 million euros impact from the expected disposal of South Korea / Solvency II capitalization ratio resilient at 186 percent as of June 30, 2016 / Operating profit outlook for 2016 confirmed within target range of 10.5 billion euros, plus or minus 500 million euros
